-
December 9, 2021 Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ DerivativeFurther in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically...
-
December 8, 2021 You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study ShowsEvidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an...
-
December 7, 2021 Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey FindsThe report also explores how microdosing may impact the use of other prescribed mental health...
-
December 6, 2021 Psychedelic Holiday Gift Guide 2021: 12 Ideas for Spreading Trippy Cheer This YearFrom a fantastic companion book to critically acclaimed documentary "Fantastic Fungi" to a new vinyl...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
December 2, 2021 Celebrities: Are They Helping or Harming the Psychedelic Movement?Two industry insiders weigh in on the question as more and more of the world's...
-
December 1, 2021 Why It’s Smart to Put Down Your Phone and Start Journaling InsteadJournaling is a key practice for integrating psychedelic experiences into our everyday lives, but it’s...
-
December 1, 2021 Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy TrialChief Medical Officer Dr. Guy Goodwin clarifies "COMP360 psilocybin therapy was generally well-tolerated" by patients...
-
November 30, 2021 Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical TrialsNine out of the 11 chronic pain sufferers interviewed say they experienced some kind of...
-
November 30, 2021 New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression“If the results are confirmed in subsequent studies ... antidepressants may no longer need to...
